Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

著者: Bengt Fellström, Jonathan Barratt, H. Terence Cook, Rosanna Coppo, John Feehally, Johan W. de Fijter, Jürgen Floege, Gerd R. Hetzel, Alan G. Jardine, Francesco Locatelli, Bart Maes, Alex Mercer, Fernanda Ortiz, Manuel Praga, Søren Schwartz Sørensen, Vladimı́r Tesař, Lucia Del Vecchio - The Lancet 2017 被引用: 402